1. Home
  2. ASB vs ICUI Comparison

ASB vs ICUI Comparison

Compare ASB & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Associated Banc-Corp

ASB

Associated Banc-Corp

HOLD

Current Price

$26.37

Market Cap

4.5B

Sector

Finance

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$142.31

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASB
ICUI
Founded
1861
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.9B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
ASB
ICUI
Price
$26.37
$142.31
Analyst Decision
Hold
Buy
Analyst Count
11
5
Target Price
$28.82
$182.25
AVG Volume (30 Days)
2.0M
270.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.64%
N/A
EPS Growth
N/A
100.62
EPS
N/A
0.03
Revenue
N/A
$2,231,262,000.00
Revenue This Year
$19.08
N/A
Revenue Next Year
$7.73
$4.10
P/E Ratio
$10.23
$4,754.33
Revenue Growth
N/A
N/A
52 Week Low
$18.32
$107.02
52 Week High
$29.52
$160.29

Technical Indicators

Market Signals
Indicator
ASB
ICUI
Relative Strength Index (RSI) 41.51 40.25
Support Level $25.29 $142.11
Resistance Level $27.69 $151.64
Average True Range (ATR) 0.86 6.62
MACD -0.27 -1.01
Stochastic Oscillator 30.43 18.31

Price Performance

Historical Comparison
ASB
ICUI

About ASB Associated Banc-Corp

Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: